Atlas Trials

Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations

Clinical trial NCT03877991 · UNKNOWN

Trial details

NCT number
NCT03877991
Sponsor
Hadassah Medical Organization
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Pain
Start date
2024-02-19
Primary completion
2025-02-19
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.